| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908181A1 Remedy for rosacea |
| 04/14/1999 | EP0908179A1 Treatment of cell-mediated immune diseases |
| 04/14/1999 | EP0907650A1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 04/14/1999 | EP0907353A1 Slimming cosmetic composition containing a chrysanthellum indicum extract |
| 04/14/1999 | EP0907350A2 A barrier cream comprising hexamethylenetetramine or derivative thereof |
| 04/14/1999 | EP0683760B1 Dehydrogenation processes and equipment therefor |
| 04/14/1999 | EP0595924B1 Platelet activating factor antagonists |
| 04/14/1999 | CN1214048A Benzopyran derivatives having leukotriene-antagonistic action |
| 04/14/1999 | CN1213548A Method for prodn. of pills for growing hair |
| 04/13/1999 | US5894019 Topically applied pharmaceutical composition, method of preparing it and its use |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016755A1 Novel angiogenesis inhibitors |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016472A1 Stable compositions containing biologically active components |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999016415A1 Use of ellagic acid and its derivatives in cosmetics and dermatology |
| 04/08/1999 | WO1999010322B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 04/08/1999 | WO1999004752A9 Methods for treating skin pigmentation |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/08/1999 | CA2303830A1 Novel angiogenesis inhibitors |
| 04/08/1999 | CA2273028A1 Stable compositions containing biologically active components |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/07/1999 | EP0906919A2 Novel integrin-binding peptides |
| 04/07/1999 | EP0906752A1 Use of a plant extract of the Rosaceae family |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |
| 04/07/1999 | EP0906114A2 Antipsoriatic compositions, method of making, and method of using |
| 04/07/1999 | EP0906112A2 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
| 04/07/1999 | EP0906096A1 Agent for inhibiting leukocyte invasion of tissues |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0906086A1 Composition |
| 04/07/1999 | EP0906078A1 Use of tempol in the prevention of photoaging |
| 04/07/1999 | EP0906077A1 Skin care compositions |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |
| 04/07/1999 | EP0570454B1 Novel steroids |
| 04/07/1999 | EP0481994B1 Metallo-organic cobalt compounds and uses thereof |
| 04/07/1999 | CN1213364A Cinnamylidene camphor derivatives and their use as UV-A protecting agents |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
| 04/07/1999 | CN1213302A Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891435 Antidiabetic agents and antigens |
| 04/06/1999 | US5891075 Hydrolysis, acetic acid |
| 04/06/1999 | CA2151774C Skin disinfecting formulations |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 04/01/1999 | WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015494A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 04/01/1999 | WO1999015493A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 04/01/1999 | WO1999015490A1 C3a receptor ligands |
| 04/01/1999 | WO1999015164A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 04/01/1999 | WO1999015149A1 Method and composition for causing skin lightening |
| 04/01/1999 | WO1999015148A1 Resorcinol derivatives |
| 04/01/1999 | WO1999003826A3 Metalloproteinase inhibitors |
| 04/01/1999 | WO1999002133A3 Topical application of a combination of benzoyl peroxide and a second active ingredient |
| 04/01/1999 | WO1998051321A9 Tissue factor for influencing blood vessel formation |
| 04/01/1999 | DE19742263A1 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva New specific immunophilin ligands as anti-asthmatics, anti-allergic, anti-inflammatory drugs, immunosuppressants, anti-psoriasis, neuroprotective agents |
| 04/01/1999 | CA2304879A1 New tetracycles, process for their production and pharmaceutical preparations containing these compounds |
| 04/01/1999 | CA2304452A1 Method and composition for causing skin lightening |
| 04/01/1999 | CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 04/01/1999 | CA2304129A1 Tie ligand homologues |
| 04/01/1999 | CA2303943A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 04/01/1999 | CA2303883A1 C3a receptor ligands |
| 04/01/1999 | CA2303405A1 53bp2 complexes |
| 04/01/1999 | CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 04/01/1999 | CA2246004A1 A kringle-related clone, hthbz47 |
| 03/31/1999 | EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it |
| 03/31/1999 | EP0905245A1 Staphylococcal polypeptides Spo0J1 |
| 03/31/1999 | EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue |
| 03/31/1999 | EP0905238A2 Pigrl-1, a member of immunoglobin gene superfamily |
| 03/31/1999 | EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily |
| 03/31/1999 | EP0905233A2 Staphylococcus aureus trigger factor |
| 03/31/1999 | EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them |
| 03/31/1999 | EP0905126A1 Metalloproteinase inhibitors |
| 03/31/1999 | EP0905118A1 Unsaturated 6-tert-butyl-1,1-dimethylindane derivates substituted in the 4-position and their use in human and veterinary medicine as well as in cosmetics |
| 03/31/1999 | EP0904777A1 Use of an excitatory amino acids inhibitor in cosmetic or dermatological compositions for sensitive kin and composition obtained |
| 03/31/1999 | EP0904774A1 Resorcinol derivatives |
| 03/31/1999 | EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 03/31/1999 | EP0904073A1 Zwitterionic compositions and methods as biological response modifiers |
| 03/31/1999 | EP0904042A1 Cosmetic composition for rejuvenation of skin without skin irritation |
| 03/31/1999 | EP0591378B1 Method of preventing and treating chemotherapy-induced alopecia |
| 03/31/1999 | CN1212723A Disinfecting compositions and process for disinfecting surfaces |
| 03/31/1999 | CN1212696A Pyrimido [5,4-d] pyrimidines, medicaments containing these componds, their use and process for their production |
| 03/31/1999 | CN1212695A 4-amino pyrimidine derivates, medicament containing these compounds, their use |
| 03/31/1999 | CN1212694A Pyrimido [5,4-D] pyrimidines, medicaments containing these compounds, their use and process for their production |
| 03/31/1999 | CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 03/31/1999 | CN1212633A Disinfecting compositions and processes for disinfecting surfaces |
| 03/30/1999 | US5889143 Evaluation and treatment of patients with progressive immunosuppression |
| 03/30/1999 | US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 03/30/1999 | US5888994 Anticancer agnets; antitumor agents; glandular disorders |
| 03/30/1999 | US5888988 Wound healing agent |